Science. 1995 Mar 24;267(5205):1782-8.

Tyrosine kinase inhibition: an approach to drug development.

Source

Department of Biological Chemistry, Alexander Silberman Institute of Life Sciences, Hebrew University of Jerusalem, Israel.

Abstract

Protein tyrosine kinases (PTKs) regulate cell proliferation, cell differentiation, and signaling processes in the cells of the immune system. Uncontrolled signaling from receptor tyrosine kinases and intracellular tyrosine kinases can lead to inflammatory responses and to diseases such as cancer, atherosclerosis, and psoriasis. Thus, inhibitors that block the activity of tyrosine kinases and the signaling pathways they activate may provide a useful basis for drug development. This article summarizes recent progress in the development of PTK inhibitors and demonstrates their potential use in the treatment of disease.

PMID:: 7892601; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Supplemental Content

Save items

Related citations in PubMed

Review Inhibitors of tyrosine kinases in the treatment of psoriasis. [Curr Pharm Des. 2000]
Review Inhibitors of tyrosine kinases in the treatment of psoriasis.
Ben-Bassat H, Klein BY. Curr Pharm Des. 2000 Jun; 6(9):933-42.
Review Biological activity of tyrosine kinase inhibitors: novel agents for psoriasis therapy. [Curr Opin Investig Drugs. 2001]
Review Biological activity of tyrosine kinase inhibitors: novel agents for psoriasis therapy.
Ben-Bassat H. Curr Opin Investig Drugs. 2001 Nov; 2(11):1539-45.
Dissection of T cell antigen receptor signaling using protein tyrosine kinase inhibitors. [Eur J Immunol. 1994]
Dissection of T cell antigen receptor signaling using protein tyrosine kinase inhibitors.
Baldari CT, Telford JL. Eur J Immunol. 1994 May; 24(5):1046-52.
Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways. [Hypertension. 1997]
Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways.
Touyz RM, Schiffrin EL. Hypertension. 1997 Aug; 30(2 Pt 1):222-9.
Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors. [Br J Cancer. 1993]
Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors.
Gillespie J, Dye JF, Schachter M, Guillou PJ. Br J Cancer. 1993 Dec; 68(6):1122-6.

See reviews... See all...

Cited by over 100 PubMed Central articles

From Transplant to Tablets: A paradigm shift in Oncology. [Sultan Qaboos Univ Med J. 2012]
From Transplant to Tablets: A paradigm shift in Oncology.
Burney IA, Al-Moundhri MS. Sultan Qaboos Univ Med J. 2012 Nov; 12(4):402-5. Epub 2012 Nov 20.
Virtual Screening of Specific Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors from the National Cancer Institute (NCI) Molecular Database. [Int J Mol Sci. 2012]
Virtual Screening of Specific Insulin-Like Growth Factor 1 Receptor (IGF1R) Inhibitors from the National Cancer Institute (NCI) Molecular Database.
Fan C, Huang YX, Bao YL, Sun LG, Wu Y, Yu CL, Zhang Y, Song ZB, Zheng LH, Sun Y, et al. Int J Mol Sci. 2012 Dec 14; 13(12):17185-209. Epub 2012 Dec 14.
Intrinsic regulation of hemangioma involution by platelet-derived growth factor. [Cell Death Dis. 2012]
Intrinsic regulation of hemangioma involution by platelet-derived growth factor.
Roach EE, Chakrabarti R, Park NI, Keats EC, Yip J, Chan NG, Khan ZA. Cell Death Dis. 2012 Jun 21; 3:e328. Epub 2012 Jun 21.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Tyrosine kinase inhibition: an approach to drug development.
Tyrosine kinase inhibition: an approach to drug development.
Science. 1995 Mar 24 ;267(5205):1782-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: